In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Corange Signs Back-to-Back, Big Money Biotech Deals...Again

Executive Summary

Corange shocked the industry in 1993 with its two blockbuster $200+ million late stage alliances with CellPro and Protein Design Labs. Corange was then run by Max Link--let go after both employee revolutions and board disagreement with his high-risk biotech vision. Now Corange has signed two early stage collaborations that could bring over $150 million in total to biotechs GeneMedicine and Sequana Therapeutics. But the structures are far more conservative than those done under Link.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts